World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
40951
World Ranking
14844
National Ranking
7505

Peter K. Kaiser publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter K. Kaiser sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 592 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter K. Kaiser D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter K. Kaiser sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter K. Kaiser is affiliated with the Cleveland Clinic in the United States. Their research primarily focuses on medicine, with significant contributions to the field of ophthalmology. They have published extensively on topics related to retinal diseases and treatments, retinal imaging and analysis, and ocular conditions, including glaucoma and Behçet's syndrome.

The main topics covered in their research include:

  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Retinal and Optic Conditions
  • Glaucoma and retinal disorders
  • Ocular Diseases and Behçet's Syndrome
  • Meta-analysis and systematic reviews
  • Health Systems, Economic Evaluations, Quality of Life

Their work spans several subfields of study, such as:

  • Ophthalmology
  • Radiology, Nuclear Medicine and Imaging
  • Economics and Econometrics
  • Molecular Biology
  • Immunology

Peter K. Kaiser has collaborated frequently with several coauthors, reflecting a network of ongoing research partnerships. These include:

  • Charles C. Wykoff
  • Varun Chaudhary
  • Sobha Sivaprasad
  • Frank G. Holz
  • Rishi P. Singh

The scientist's research has been published in various venues, with a concentration in specialized ophthalmology journals:

  • Eye
  • Ophthalmology Retina
  • Ophthalmic Surgery, Lasers & Imaging Retina
  • Ophthalmology
  • Journal of VitreoRetinal Diseases

Notable recent publications include:

  • Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab, 2020, Ophthalmology
  • Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial, 2023, The Lancet
  • Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration, 2021, JAMA Ophthalmology
  • Review of gene therapies for age-related macular degeneration, 2022, Eye
  • Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care, 2022, Acta Ophthalmologica

Best Publications

  • Ranibizumab for Neovascular Age-Related Macular Degeneration

    Philip J. Rosenfeld;David M. Brown;Jeffrey S. Heier;David S. Boyer

  • Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

    David M. Brown;Peter K. Kaiser;Mark Michels;Gisele Soubrane

  • Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

    Jeffrey S. Heier;David M. Brown;Victor Chong;Jean Francois Korobelnik

  • Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

    David M. Brown;Mark Michels;Peter K. Kaiser;Jeffrey S. Heier

  • The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole.

    Jay S. Duker;Peter K. Kaiser;Susanne Binder;Marc D. de Smet

  • Intravitreal aflibercept for diabetic macular edema.

    Jean François Korobelnik;Diana V. Do;Ursula Schmidt-Erfurth;David S. Boyer

  • Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration: Ninety-Six–Week Results of the VIEW Studies

    Ursula Schmidt-Erfurth;Peter K. Kaiser;Jean François Korobelnik;David M. Brown

  • HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists.

    Evan B. Dreyer;Peter K. Kaiser;Jeffrey T. Offermann;Stuart A. Lipton

  • Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.

    David M. Brown;Ursula Schmidt-Erfurth;Diana V. Do;Frank G. Holz

  • Acute endophthalmitis following intravitreal triamcinolone acetonide injection

    Darius M Moshfeghi;Peter K Kaiser;Ingrid U Scott;Jonathan E Sears

  • Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin - 1-year results of a randomized clinical trial - VIP report no. 1

    J. Arnold;D. Kilmartin;J. Olson;S. Neville

  • Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity

    Stuart A. Lipton;Nikolaus J. Sucher;Peter K. Kaiser;Evan B. Dreyer

  • RANIBIZUMAB FOR PREDOMINANTLY CLASSIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: SUBGROUP ANALYSIS OF FIRST-YEAR ANCHOR RESULTS

    Peter K. Kaiser;David M. Brown;Kang Zhang;Henry L. Hudson

  • Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies

    Jeffrey S. Heier;Jean François Korobelnik;David M. Brown;Ursula Schmidt-Erfurth

  • Neovascular age-related macular degeneration: potential therapies

    Aimee V. Chappelow;Peter K. Kaiser

  • Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis).

    Peter K. Kaiser

  • Optical coherence tomographic patterns of diabetic macular edema.

    Brian Y. Kim;Scott D. Smith;Peter K. Kaiser

  • Environmental Epidemiology, Volume 1: Public Health and Hazardous Wastes

    Unknown

  • Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.

    Peter K. Kaiser;Barbara A. Blodi;Howard Shapiro;Nisha R. Acharya;Nisha R. Acharya

  • Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center.

    Monica I. Binder;Jimmy Chua;Peter K. Kaiser;Gary W. Procop

Frequent Co-Authors

Mark P. Stevens
Mark P. Stevens University of Edinburgh
David A. Hume
David A. Hume University of Queensland
Lan Huang
Lan Huang University of California, Irvine
David W. Burt
David W. Burt University of Queensland
Georgios Banos
Georgios Banos Scotland's Rural College
Paul Barrow
Paul Barrow University of Surrey
Robert M. Christley
Robert M. Christley University of Liverpool
Olivier Hanotte
Olivier Hanotte University of Nottingham
Michael H. Kogut
Michael H. Kogut Agricultural Research Service
Nat Bumstead
Nat Bumstead Newbury College

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in pursuing a medical career but looking for flexible options? Many online degrees and certifications can offer practical entry points or advancement opportunities in healthcare.

For those beginning their journey, an HIM associate degree online provides a foundational understanding of managing patient records and health data, making it suitable for administrative or IT-focused careers in medicine.

If you’re seeking a quick, direct way into the healthcare field, consider medical coding. The medical billing and coding certification cost is generally lower than traditional degrees, making this a cost-effective path with strong job demand.

For nurses wanting to enhance their skills or scope of practice, exploring the most affordable nurse practitioner programs can open doors to advanced care roles. Alternatively, online nursing programs offer flexibility for students balancing work or home responsibilities while earning a nursing degree.

Each of these pathways provides different routes into healthcare, allowing you to tailor your education to your career goals, budget, and lifestyle.

Best Scientists Citing Peter K. Kaiser

Trending Scientists

Recently Published Articles